PRESS RELEASE

PRESS RELEASE

View printer-friendly version << Back

Novavax CEO to Present at Piper Jaffray London Health Care Conference

ROCKVILLE, Md., June 14 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) Chief Executive Officer Dr. Rahul Singhvi will present at the 2nd Annual Piper Jaffray London Health Care Conference at 4:40 p.m. local time at the Great Eastern Hotel in London on June 21, the company announced today.

Dr. Singhvi will provide an overview of the company's strategy, research and development progress and strategic partnerships. A link to a (LIVE) audio webcast of his presentation will be available at 11:40 a.m. Eastern time on Thursday, June 21, through the company's website, www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 30 days.

ABOUT NOVAVAX

Novavax Inc. is committed to leading the global fight against infectious disease by creating novel, highly potent vaccines that are safer and more effective than current preventive options. Using the company's proprietary virus-like particle (VLP) and Novasome(R) adjuvant technologies, Novavax is developing vaccines to protect against H5N1 pandemic influenza, seasonal flu and other viral diseases. Novavax's particulate vaccines closely match disease-causing viruses while lacking the genetic material to cause disease, which provides potential for greater immune protection at lower doses than current vaccines. With an exclusive portable manufacturing system that allows for rapid mass-production of vaccines, Novavax is uniquely positioned to meet global public health needs.

SOURCE Novavax Inc.

CONTACT: Mariann Caprino of Novavax Inc.,
+1-240-268-2029